Company intelligence / Profile preview

Reproductive Genetic Innovations

Northbrook, Illinois, United Statesrgiscience.com ↗

Ownership: Private
Employees: ~14
Development stage: Commercial

Overview

RGI has over three decades of experience in preimplantation genetic testing and has facilitated the birth of more than 10,000 healthy babies. The company pioneered many PGT techniques and remains a global leader in comprehensive embryo screening for single gene defects and chromosomal abnormalities. No clinical trial results are applicable as it provides diagnostic/laboratory services rather than therapeutics.

Therapeutic areas: HematologyWomen's Health
Modalities: Diagnostic test (Preimplantation Genetic Testing)Laboratory service (Genetic Counseling)In vitro fertilization support services
Industry: Molecular Diagnostics

Partnerships

No major pharmaceutical or biotech partnerships publicly listed.

Beyond the preview

Go deeper on Reproductive Genetic Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reproductive Genetic Innovations.

Explore the full profile